Tag: FDA
Atopic Dermatitis Market Forecast Report 2025-2034 | FDA – GlobeNewswire
eczemarelief
July 23, 2025
Chronic Hand Eczema Pipeline 2025: FDA Approvals, Therapies, – openPR.com
eczemarelief
May 6, 2025
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis – Physician's Weekly
eczemarelief
December 19, 2024
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval – Everyday Health
eczemarelief
September 18, 2024